Skip to main content

Advertisement

ADVERTISEMENT

AMP 2023

FDA Determination: Data Does Not Support an Excess Mortality Risk for Paclitaxel-Coated Devices

Ramon Varcoe, MBBS, PhD

Prince of Wales Hospital, Sydney, Australia

In this video recorded at AMP 2023, vascular surgeon Dr. Ramon Varcoe, from Prince of Wales Hospital in Sydney, Australia, talks about his presentation on the new FDA determination that paclitaxel-coated devices do not pose an excess mortality risk in patients and discusses the implications of this decision.

Advertisement

Advertisement

Advertisement